BioCentury | May 2, 2013
Tools & Techniques

CTCs gain character(ization)

...has started clinical trials of its tests in colon cancer, melanoma and glioblastoma multiforme (GBM). NX PharmaGen...
...Cambridge, Mass. Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. Massachusetts General Hospital , Boston, Mass. NX PharmaGen...
Items per page:
1 - 1 of 1
BioCentury | May 2, 2013
Tools & Techniques

CTCs gain character(ization)

...has started clinical trials of its tests in colon cancer, melanoma and glioblastoma multiforme (GBM). NX PharmaGen...
...Cambridge, Mass. Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. Massachusetts General Hospital , Boston, Mass. NX PharmaGen...
Items per page:
1 - 1 of 1